FLGT - Fulgent Genetics Inc
Fulgent Genetics Inc Logo

FLGT - Fulgent Genetics Inc

https://www.fulgentgenetics.com
Strong Sell Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.

52W High
$23.56
52W Low
$14.57
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.82
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
7.94
EV/EBITDA (<8 favorable)
-4.34
EV/Revenue (<3 favorable)
1.27
P/S (TTM) (<3 favorable)
2.22
P/B (<3 favorable)
0.60
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
33.16%
Institutions (25–75% balanced)
53.82%
Shares Outstanding
30,609,000
Float
18,639,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
303,223,000
Gross Profit (TTM)
121,401,000
EPS (TTM)
-1.66
Profit Margin (>10% good)
-0.17%
Operating Margin (TTM) (higher better)
-0.24%
ROE (TTM) (>15% strong)
-0.05%
EPS YoY (Quarterly) (>10% good)
-0.99
Revenue YoY (Quarterly) (>8% good)
0.15
Momentum
Bearish momentum
Value
0.5357
Previous
0.5937
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025